Latest filing published 06 Jul 2026 for Abeona Therapeutics INC., €560k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Silverstein Christine Berni discloses dealings in Abeona Therapeutics Inc. to SEC (Form 4). We count 2 filings; the first trade dates from 15 June 2026 and the latest from 6 July 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 6 July 2026, the filings show a transaction worth €560k in Abeona Therapeutics Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations